Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background: Type 2 diabetes (T2D) disproportionately affects youth with public insurance of minority and lower socioeconomic status backgrounds. We aimed to determine feasibility of CGM use in this understudied population. Methods: We enrolled youth <20 years old with T2D, provided or prescribed intermittent scanned CGM, and followed established clinic workflows with six data collection visits over 12-months. CGM use was measured by % wear time per two-week period (>75% wear-time as goal) from downloaded report prior to clinic visit. Exploratory outcomes included: 14-day CGM wear time in range (TIR: % time spent between 70 and 180 mg/dl), HbA1c, and patient-reported outcomes (PROs) collected from youth and parents. Results: We enrolled 30 youth (age 15.1 years [SD 2.48]; HbA1c 10.2%, range: 6.5%-15.5%), 46.7% female, 90% Hispanic. At baseline, 37% previously used CGM and 53% lacked glucometer data. CGM use was 50% at three months and 23% at 12 months. CGM wear time decreased by 6.4 days per two weeks by 12 months. Mean HbA1c was 9.8% at 12 months and median TIR decreased from 71% to 42%. Parents and youth had moderate-to-positive attitudes about diabetes technology. Youth endorsed fair levels of global health; and youth and parents endorsed fair general and diabetes-related health-related quality of life. Conclusions: Strategies for sustained CGM use in youth with T2D may differ from adults with T2D or youth with type 1 diabetes. Additional studies are needed to evaluate facilitators and barriers of sustained CGM use to optimize CGM use in youth with T2D. Clinicaltrials.gov registration: NCT05074667.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While initial uptake of CGM may be encouraging, sustained use often declines over time because of device burden, skin issues, costs, and access barriers [25].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [25]
In the citing paper
“These observations underscore that, although CGM can provide the data backbone for many DHT applications, specific strategies are needed to support long‑term acceptability and continuous use in people with EOT2D [25].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [25]
In the citing paper
“Notably, existing studies in EOT2D are limited by small sample sizes, with pilot randomized and feasibility studies reporting short-term improvements in glycemic profiles and acceptability of CGM among publicly insured or clinic-based EOT2D [18, 25].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young-Hyman, D., de Groot, M., Hill-Briggs, F., Gonzalez, J. S., Hood, K., & Peyrot, M. (2016) · Diabetes Care · doi:10.2337/dc16-2053 · Cited by 1,072
Self-citationLong-term complications in youth-onset type 2 diabetes
TODAY Study Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100165 · Cited by 546
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349
Tanenbaum, M. L., Hanes, S. J., Miller, K. M., Naranjo, D., Bensen, R., & Hood, K. K. (2017) · Diabetes Care · doi:10.2337/dc16-1536 · Cited by 296
Self-citationAddala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., Walker, A., Rosenbauer, J., Maahs, D. M., & Holl, R. W. (2021) · Diabetes Care · doi:10.2337/dc20-0257 · Cited by 283
Self-citationREDEEM: A pragmatic trial to reduce diabetes distress
Fisher, L., Hessler, D., Glasgow, R. E., Arean, P. A., Masharani, U., Naranjo, D., & Strycker, L. A. (2013) · Diabetes Care · doi:10.2337/dc12-2493 · Cited by 266 · cited 1×
“15 In contrast, CGM is the standard of care for youth with T1D, improves glycemic control and quality of life, 16,17 and initiation is feasible and well-accepted.”
DeSalvo, D. J., Miller, K. M., Hermann, J. M., Maahs, D. M., Hofer, S. E., Clements, M. A., Lilienthal, E., Sherr, J. L., Tauschmann, M., Holl, R. W., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12711 · Cited by 233 · cited 1×
“15 In contrast, CGM is the standard of care for youth with T1D, improves glycemic control and quality of life, 16,17 and initiation is feasible and well-accepted.”
Self-citationThe RISE Consortium, Nadeau, K. J., Hannon, T. S., Edelstein, S. L., Arslanian, S. A., Caprio, S., Leschek, E. W., Zeitler, P. S., Buchanan, T. A., Ehrmann, D. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0787 · Cited by 176
Wright, E. E., Kerr, M. S. D., Reyes, I. J., Nabutovsky, Y., & Miller, E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0069 · Cited by 115 · cited 1×
“41,42 Our study utilized an intermittently scanned CGM device, requiring user engagement which likely contributed to low data capture; real-time CGM or scheduled intermittent CGM may improve engagement in CGM use and outcomes.”
Research works printed but not linked: 29
- 10.1056/NEJMoa1610187 · DOI · Paper page
- 10.1001/jama.2017.0686 · DOI · Paper page
- 10.1016/j.jcjd.2014.03.005 · DOI
- 10.1001/jama.2021.11165 · DOI · Paper page
- 10.1056/NEJMoa1109333 · DOI · Paper page
- 10.1111/pedi.13409 · DOI · Paper page
- 10.1111/pedi.12377 · DOI
- 10.2337/dc24-S014 · DOI · Paper page
- 10.1210/jendso/bvab013 · DOI · Paper page
- 10.2337/dc13-1124 · DOI
- 10.2337/dc15-0078 · DOI · Paper page
- 10.2337/dc19-1205 · DOI · Paper page
- 10.1089/dia.2018.0204 · DOI · Paper page
- 10.1038/s41591-024-02975-y · DOI
- 10.1001/jamanetworkopen.2023.8881 · DOI
- 10.1016/j.nedt.2003.10.001 · DOI · Paper page
- 10.1111/dme.13841 · DOI
- 10.1093/jpepsy/jsx146 · DOI · Paper page
- 10.1111/j.1399-5448.2010.00720.x · DOI · Paper page
- 10.1007/s11136-013-0581-8 · DOI · Paper page
- 10.1007/s11136-015-1111-7 · DOI
- 10.1016/j.jadohealth.2017.05.030 · DOI
- 10.1136/bmj.39335.541782.AD · DOI · Paper page
- 10.1213/ANE.0000000000002864 · DOI · Paper page
- 10.1177/26350106231205030 · DOI
- 10.1007/s11892-017-0905-0 · DOI
- 10.1159/000528205 · DOI
- 10.1016/j.jcjd.2023.04.001 · DOI · Paper page
- 10.1089/dia.2024.0539 · DOI · Paper page
Cited by
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Metadata
- Authors
- Shah, S., Tanenbaum, M. L., Loyola, A., Sala, N. G. L., Darji, H., Hanes, S., Bishop, F. K., Hood, K. K., & Maahs, D. M.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2025-09-20
- Volume
- 20
- Issue
- 6
- Pages
- 1807-1816
- ISSN
- 1932-2968
- Cited by
- 2
- References
- 15
- Language
- en
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Funders
- Stanford Diabetes Research Center (P30DK116074)
- Stanford REDCap – Stanford Medicine Research Technology team
- NIH funding source of Stanford’s Center for Clinical and Translational Education and Research award, under the Biostatistics, Epidemiology and Research Design (BERD) Program
- Stanford Maternal and Child Health Research Institute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study. https://app.cochat.ai/papers/10.1177/19322968251368366
- The paper
- Shah, S., Tanenbaum, M. L., Loyola, A., Sala, N. G. L., Darji, H., Hanes, S., Bishop, F. K., Hood, K. K., & Maahs, D. M. (2026). Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968251368366
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.